KALV
KALV
NASDAQ · Biotechnology

Kalvista Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$27.00
+0.01 (+0.04%)
As of Jun 21, 10:15 PM ET ·
Analyst Consensus
Hold
13
Analysts
Moderate
Coverage
Buy 7 54%
Hold 6 46%
Sell 0 0%
Price Target
Analyst Price Target +139.9% upside
Low Target $35.35
Average Target $64.76
High Target $75.74
Current Price $27.00
Current
$27.00
Target
$64.76
$35.35 $64.76 avg $75.74
Scenario Analysis
Bear Case
$35.35
30.9%
Low target
Base Case
$64.76
+139.9%
Avg target
Bull Case
$75.74
+180.5%
High target
Risk/Reward
5.8x
Highly favorable
Price in Context
52-Week High
$27.00
0.0% from high
52-Week Low
$9.83
+174.7% from low
Target vs 52W High
$64.76
+139.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%